Mwyngil Therapeutics Partners with Expert Systems to Enhance GPR75 Research for Chronic Diseases Mwyngil Therapeutics has signed a significant licensing agreement with Expert Systems Inc. to enhance therapies for chronic diseases like obesity and diabetes.

Mwyngil Therapeutics Partners with Expert Systems to Enhance GPR75 Research for Chronic Diseases #United_States #Dover #Expert_Systems #Mwyngil_Therapeutics #GPR75_Modulators